Your browser doesn't support javascript.
loading
Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145.
Wu, Jing; Du, Mingyu; Zhang, Qian; Zhang, Wenjun; Fan, Yanxin; Yin, Li; Fei, Qian; Jiang, Xuesong; Chen, Wei; Zhu, Huanfeng; Yan, Pengwei; He, Xia; Bian, Xiuhua.
Afiliación
  • Wu J; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Du M; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Zhang Q; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Zhang W; The Fourth Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Fan Y; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Yin L; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Fei Q; The Fourth Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiang X; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Chen W; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Zhu H; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Yan P; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • He X; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
  • Bian X; Department of Radiotherapy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, hexiabm@163.com; bianxiuhua_flk@sina.com.
Onco Targets Ther ; 11: 7483-7492, 2018.
Article en En | MEDLINE | ID: mdl-30498361
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2018 Tipo del documento: Article